|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 CAD | +1.62% |
|
+1.62% | +106.59% |
| 15/19/15 | Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
| 19/19/19 | Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index | CI |
| Market Cap | 25Cr 22Cr 20Cr 18Cr 35Cr 2.36TCr 35Cr 237.02Cr 93Cr 1.18TCr 93Cr 91Cr 3.91TCr | P/E 2017 |
-16.3x | P/E 2018 | -4.48x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 16Cr 31Cr 2.09TCr 31Cr 209.29Cr 82Cr 1.04TCr 82Cr 81Cr 3.45TCr | EV / Sales 2017 |
7,23,52,077x | EV / Sales 2018 | 1,09,15,686x |
| Free-Float |
98.36% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +1.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tricia Symmes
CEO | Chief Executive Officer | - | - |
Nick Dean
CEO | Chief Executive Officer | - | 01/12/2017 |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Morrison
BRD | Director/Board Member | 44 | - |
| Director/Board Member | - | 06/11/2018 | |
John H. Stewart
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.62% | +1.62% | - | - | 0 | ||
| -1.13% | +1.13% | -8.15% | -3.96% | 1.38TCr | ||
| -1.30% | +1.34% | -29.93% | -50.51% | 530.03Cr | ||
| -1.44% | +5.41% | +5.61% | +9.42% | 523.32Cr | ||
| +0.42% | +0.30% | +2.69% | -31.78% | 413.47Cr | ||
| -0.11% | +2.24% | -2.45% | -2.80% | 374.79Cr | ||
| -1.75% | -2.12% | -2.55% | +5.14% | 366.29Cr | ||
| -0.31% | -0.44% | -4.86% | +15.27% | 351.59Cr | ||
| -1.00% | -0.69% | -14.04% | -22.43% | 249.12Cr | ||
| -1.17% | +2.19% | -2.73% | +51.63% | 192.47Cr | ||
| Average | -0.62% | -0.09% | -6.27% | -3.34% | 438.2Cr | |
| Weighted average by Cap. | -0.93% | -0.23% | -7.00% | -6.82% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 2.69 2.34 2.18 2 3.79 256.26 3.83 25.71 10.05 128.1 10.12 9.9 424.45 | 8.22 7.14 6.66 6.12 11.57 782.19 11.69 78.49 30.68 391.01 30.88 30.2 1.3T |
| Net income | -1.21Cr -1.05Cr -97.97L -90L -1.7Cr -115.11Cr -1.72Cr -12Cr -4.52Cr -58Cr -4.54Cr -4.44Cr -190.66Cr | -2.43Cr -2.11Cr -1.96Cr -1.8Cr -3.41Cr -230.76Cr -3.45Cr -23Cr -9.05Cr -115.35Cr -9.11Cr -8.91Cr -382.21Cr |
| Net Debt | -2.15Cr -1.87Cr -1.74Cr -1.6Cr -3.03Cr -204.63Cr -3.06Cr -21Cr -8.03Cr -102.29Cr -8.08Cr -7.9Cr -338.93Cr | -2.91Cr -2.52Cr -2.35Cr -2.16Cr -4.09Cr -276.36Cr -4.13Cr -28Cr -11Cr -138.15Cr -11Cr -11Cr -457.74Cr |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- EMC Stock
Select your edition
All financial news and data tailored to specific country editions
















